Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Kingworld Medicines Group Ltd. ( (HK:1110) ) is now available.
Kingworld Medicines Group Ltd. reported a significant decline in its financial performance for the first half of 2025, with revenue dropping by 23% and profit attributable to owners of the company turning into a loss compared to the same period in 2024. The company’s gross profit margin slightly decreased, and overall profit for the period fell by 74.9%, reflecting challenges in maintaining profitability amidst rising administrative expenses and reduced sales.
The most recent analyst rating on (HK:1110) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Kingworld Medicines Group Ltd. stock, see the HK:1110 Stock Forecast page.
More about Kingworld Medicines Group Ltd.
Kingworld Medicines Group Ltd. operates in the pharmaceutical industry, focusing on the distribution and retail of medicines and healthcare products. The company is involved in the sale of pharmaceutical and healthcare products, catering to a broad market with a variety of offerings.
Average Trading Volume: 1,237,740
Technical Sentiment Signal: Buy
Current Market Cap: HK$376M
For detailed information about 1110 stock, go to TipRanks’ Stock Analysis page.